GlaxoSmithKline: Making an impact on emerging markets

Authored by Abbas Hussain, Senior Partner, C-Bridge Capital

Criticaleye recently caught up with Abbas Hussain, President, Emerging Markets at GlaxoSmithKline, to discuss the state of  emerging markets and the initial stages of GSK’s low-cost drug plan, a revolutionary scheme set to change the face of the pharmaceutical industry.

Share this with your Community





Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.


Click here to download this insight

VIEWPOINTS | International Expansion in a Nutshell

Once a business has reached maturity in its home market, attention naturally turns to international expansion as the next growth frontier.   Nick Burns has first-hand experience of this during his time as ...


Inspiring Leaders Podcast: Claire Ainscough, CPO at Ocado on Leading People and Culture

Claire Ainscough, Chief People Officer (CPO) at Ocado Group joins Bridgette Hall to explore what it takes to lead the people agenda in a fast-moving, technology-driven business. As ...


Click here to download this insight

BLOG | Stepping Up to CFO – Five Key Tips

How do finance leaders prepare for a Group CFO role? At a recent Criticaleye Aspiring Group CFO Masterclass, a number of consistent themes emerged around what differen...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 192




LACE Partners Canaccord Genuity Group Inc Aldermore Group Worldpay Hitachi Solutions NATS Rolls-Royce GlaxoSmithKline plc Drax Group plc E.ON UK British Land AlixPartners CrowdStrike Stream London Stock Exchange Group NatWest Group Lightsource bp Mayborn Group Legal & General